SCARB1 and glioblastoma: These data indicate that the sensitivity of GBM cell lines to the drug containing rHDL NPs may be dependent on their respective SR-B1 expression and that the IC50 of EVR was substantially decreased against GBM cells, when delivered in rHDL NPs.